> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CVM Approves New NSAID for Arthritic Dogs
- URL: https://www.fdaweb.com/cvm-approves-new-nsaid-for-arthritic-dogs/
- Published: 2016-03-21T12:00:00.000Z
- Updated: 2026-09-14T20:50:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135137

> FDA said 3/21 that its Center for Veterinary Medicine has approved Leawood, KS-based Aratana Therapeutics’ Galliprant (grapiprant tablets), indicated to control osteoarthritis pain and inflammation in dogs. An [agency release](http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm491552.htm?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery) said the drug is a new treatment option for dogs with this condition. It is a prostaglandin E2 (PGE2) EP4 receptor antagonist; a non-cyclooxygenase inhibiting, nonsteroidal anti-inflammatory drug (NSAID). The agency said other NSAIDs approved for use in dogs include deracoxib (Deramaxx), carprofen (Rimadyl, Novocox, Carprieve, Quellin, Carprofen), meloxicam (Metacam, Loxicom, Orocam, Meloxidyl, Meloxicam), and firocoxib (Previcox).